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The injection of immunologically competent adult  F~ hybrid mice with parental T 
lymphocytes can result  in severe reduction of abrogation of immune potential  of the 
F1,  with  respect  to both  T  cell  (1-3)  and  B  ceil  (4)  responses.  This  loss of immune 
function  is  known  as  graft-vs.-host  (GVH)l-associated  immune  suppression  (5).  It 
occurs  rapidly  (within  5  d)  after  intravenous  injection  of a  single  lymphoid  cell 
inoculum,  is profound in its effects, can be long-lasting  (2 mo or more after a  single 
parental cell injection), is not antigen specific in its effects, is mediated by suppressor 
T  lymphocytes (1,  5, 6), and can be prevented by counter-suppressor T  lymphocytes 
that  are  activated  by treatment  of the  F1  with  specific  anti-H-2  antibodies  before 
injection  of parental  T  cells  (7).  GVH-associated  immune  suppression  is  probably 
under  the control of a  number of genetic  factors,  including some linked  to the  H-2 
complex  (5)  and  some  that  may not  be  H-2  linked.  The  potent  suppressive  signal 
involved in this phenomenon appears to be initiated by parental m cell recognition of 
H-2  antigens  expressed  by  the  other  parental  haplotype  of the  F1.  However,  the 
minimal major histocompatibility complex genetic differences between the F1 recipi- 
ent and the parental  lymphocyte donor that are required to activate this suppression 
are not known. 
The present study has used congeneic inbred,  intra-H-2  recombinant,  and mutant 
strains  of mice on  the  C57BL/10  and  C57BL/6  genetic  background  to  determine 
which H-2 antigens expressed by the F1 need to be recognized by parental spleen cells 
in  order  to  induce  GVH-associated  suppression.  The  findings  are  discussed  with 
respect to the H-2 genetics of this type of suppression,  as well as the possible analogy 
of this phenomenon to clinical examples of severe imfaune suppression. 
Materials  and Methods 
Mice.  The following mouse strains (with the strain abbreviations used in this report) were 
obtained from The Jackson Laboratory, Bar Harbor, ME: C57BL/6J (B6); C57BL/10Sn (B); 
B 10.A/SgSn (A); B 10.A(2R)  (2R) ; B 10.A(5R)  (5R).  The B 10.A(4R)  (4R)  strain was obtained 
from the Animal Genetics and Production Branch, National Cancer Institute (NCI). The B6.C- 
H-2  urn12 (bml2)  I-A mutant strain  (8  10) was a gift from Dr. T. H. Hansen, Merck Sharpe & 
Dohme, Rahway, NJ. The following strains were a gift from the colony of Dr. David H. Sachs, 
Immunology Branch, NCI: B10.AKM (AKM); B10. MBR (MBR); A.TL; A.TH (see Table I 
1Abbreviations used in  this paper: AIDS, acquired  immune  deficiency syndrome; CTI,,  cytotoxic T 
lymphocytes; GVtt, graft vs. host; SCID, severe combined immunodeficiency disorders; TNP, trinitro- 
phenyl. 
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for the H-2 alleles of these strains). The F1 hybrids used in this study were bred in our own 
animal colony. All experimental mice were males, 8-13 wk of age. 
Injection of F1 Mice with Parental Spleen Cells.  Cell suspensions were prepared as described 
elsewhere (5) and injected via the tail vein into F1 mice. The F~ mice were inoculated with 4- 
6 X  10  7 cells per recipient in a volume of 0.5 or 1.0 ml. 
In  Vitro Generation and Assay for  Cell-mediated Lympholysis.  The  cell-mediated lympholysis 
potential of spleen cells from normal control and injected FI mice was tested 7  14 d after the 
single inoculum of parental spleen cells by in vitro sensitization against trinitrophenyl-modified 
syngeneic  cells  (TNP-self)  or  allogeneic  cells,  as  previously  described  (11).  The  effectors 
generated 5 d later were tested for lytic activity in a 4-h  Cr-release assay on 48-h concanavalin 
A-stimulated spleen cell blasts, each of which was tested in triplicate samples at three or four 
effector:target cell ratios (11). The percent lysis was calculated as previously described (11) and 
standard errors of the mean have been omitted from the results presented for simplicity since 
they were consistently <10% of the mean values. 
Results 
General Pattern of GVH-associated  Cytotoxic  T  Lymphocyte  (CTL)  Suppression.  The 
results presented in this report illustrate data from individual experiments. However, 
it should be noted  that  each  donor-recipient strain combination was run  in at  least 
three independent  experiments, in which  CTL  potential was  tested  for responses to 
TNP-self and alloantigens at  various times after parental cell inoculum.  The results 
of such repetitive experiments were essentially identical. Similar results were obtained 
for the responses to TNP-self and  alloantigens, although  the level of suppression  to 
alloantigens was often less dramatic than that to TNP-self. For each experiment, only 
the TNP-self (Figs. 1 and 2) or allogeneic (Fig. 3) CTL responses are shown to conserve 
space.  In  some  experiments,  spleen  cells  from  nonparental,  H-2-recombinant 
strains  were  injected  (e.g.,  Fig.  1 A).  Nevertheless,  all  donor-recipient combinations 
were  selected  such  that  (a)  the  F1  recipients  should  not  recognize  the  donor  as 
allogeneic; and  (b)  the donor cells should  recognize one or more H-2  gene products 
expressed  by  the  recipient  as  allogeneic.  It  should  also  be  noted  that  we  have 
previously found  that  the  F1  mice  that  are  heterozygous  at  H-2D  are  resistant  to 
induction of CTL  suppression with parental cells that  express H-2D  b, but  that such 
resistance  can  be  overridden  by  injecting  >2  ×  10  7  parental  spleen  cells  (5).  To 
exclude any failure to detect suppression as being due to F1 resistance to the parental 
inoculum, 4-6 ×  107 spleen cells were inoculated in all experiments. 
Mapping of GVH-associated Suppression within the H-2 Complex.  The results of Fig.  1 
summarize a  series of six F1 combinations in which suppression of CTL potential to 
TNP-self was studied after injection of parental spleen cells. (B x  A)F1 mice injected 
with  A  parental  spleen  cells were  used  as  an  example  of parent  into  F1  in  which 
products of the entire H-2  b haplotype can be recognized as allogeneic by the A parent. 
As  shown  in  Fig.  1A,  injection  of  6  ×  107  parental  A,  as  well  as  2R  and  4R 
recombinant spleen cells, 7 d  before CTL testing completely abrogated the ability of 
the Fa (and that of any immunocompetent  donor cells) to generate effector activity to 
TNP-self. These results are similar to previously published data (3, 5, 6) and are used 
here for comparative purposes and as an  internal control for this study  (see below). 
The results shown  in Fig.  1 B, in which  (2R  X  B)F1 nfice were injected with 6  ×  107 
2R  or  B  spleen  cells, indicate  that  recognition  of Fa  K-S  region  H-2  products  by 
parental lymphocytes was sufficient to induce suppression  to TNP-self. The data of 
Figs.  1C  and  D,  using  (5R  ×  A)F1 and  (4R  ×  B)F1 injected with  4  ×  10 v parental 938  GRAFT-VS.-I1OST-ASSOCIATED  IMMUNE  SUPPRESSION 
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FJc.  1.  In vitro CTL potential  to TNP-self of spleen cells from El mice.  (A)  (B X A)FI mice were 
untreated  (O) or injected  with 6  X  107 A  (ml), 2R  (A), or 4R  (V! spleen cells and  tested  7 d  later. 
(B)  (2R  x  B)FI mice were untreated  (O) or injected  with 6  x  10'  2R  (A) or B  (V) spleen cells and 
tested  7 d  later.  (C)  (5R  X  A)F] mice were untreated  (O) or injected  with 4  X  107 5R  (A) spleen 
cells and  tested  13  d  later.  (D)  (4R  X  B)Fj  mice were untreated  (0)  or injected  with 4  X  107 4R 
(A) or B (V) spleen cells and tested  7 d  later.  (E)  (B X MBR)F] mice were untreated  (O) or injected 
with  6  x  1{)  7 MBR  (A)  or  B  (V)  spleen  cells  and  tested  14  d  later.  (F)  (4R  x  A)F]  mice  were 
untreated  (O) or injected  with 6  x  I07 A  (A) or 4R  (V) spleen celIs and tested  I3 d  iater. 
spleen cells, indicate that recognition of K-IB and K-IA products, respectively, is all 
that is required to induce suppression of CTL potential to TNP-self. Since all examples 
shown above (Figs.  1 A-D)  have involved recognition of F1  K  and I region products 
by parental lymphocytes, the (B X MBR)F] and (4R X A)F] combinations were used 
to determine whether K  and/or IA need to be recognized as a  minimal requirement 
for the induction  of CTL suppression.  The results indicate that  injection of 6  X  10  7 
MBR or B parental spleen cells into (B ×  MBR)F1 greatly reduced CTL potential to 
TNP-self (Fig.  1 E), whereas the injection of 6 ×  10  7 A or 4R parental spleen cells into 
(4R  X  A)F1  mice had  no  detectable  effect on  CTL potential  (Fig.  1 F).  This same 
preparation of A  and 4R cells, which did not suppress  (4R X A)F1  mice, was shown 
to be functionally viable by the cells' ability to suppress the appropriate F1  mice in 
which  K  and IA would be allogeneic to the donor inoculum  (Fig.  1 A). Thus, these 
results are consistent with the recognition of F] I-A antigens by the parental lympho- 
cytes being sufficient for the induction  of CTL suppression. 
Mapping GVH-associated Suppression to the I Region.  To investigate this phenomenon 
further,  Fl-parent  combinations  were  chosen  such  that  only  F~  K,  D,  or  I  region 
products  would  be  allogeneic  to  the  parental  cells.  (AKM  X  MBR)F1  mice  were SItEARER  AND LEVY  939 
injected  with  6  ×  107  AKM  or  MBR  parental  spleen  cells  (which  differ  only  at 
H-2K), and CTL potential was tested  13 d  later (see Fig.  2).  No reduction  in CTL 
potential to TNP-self was observed when AKM cells were injected. Only a  marginal 
reduction was detected when MBR cells were injected (Fig. 2 A). In contrast, the same 
inoculum  of MBR  cells  drastically  reduced  the  CTL  potential  of  (B  X  MBR)Ft 
(compare Fig. 2 A with Fig.  1 E). Thus, recognition of only H-2K region products did 
not  lead  to CTL suppression.  (2R  X  A)Ft  mice were injected with 6  ×  107 A or 2R 
spleen cells to determine whether recognition of H-2D only would lead to suppression. 
The data of Fig. 2 B indicate that no suppression was detected. The same preparation 
of 2R and A  spleen cells was capable of inducing suppression when injected into  (B 
X A)F1  mice (see Fig.  1A). Thus, recognition of only H-2D region products does not 
result  in  suppression.  To determine  whether  recognition  of the  I  region  without  K 
would result in suppression, (A.TH x  A.TL)F1 mice were injected with 5 X  10 7 A.TL 
spleen cells, and the CTL potential to TNP-self was tested  13 d later. The results (Fig. 
2C) illustrate that I region recognition results in abrogation of CTL potential. 
Mapping  of GVH-associated Suppression  to  I-A.  Since  recognition  of  Ft  I  region 
determinants by parental lymphocytes is all that is required  to induce CTL suppres- 
sion, we have investigated whether recognition of only I-A determinants would induce 
suppression.  This was done  by taking advantage of the  H-2  bmlz  loss-gain  mutation 
that maps within I-A (8-10).  (B6 ×  bml2)F1  mice were injected with 5  ×  10 7 B6 or 
bm 12 spleen cells. The same preparations of B6 and bm 12 cells were also injected into 
(B6 ×  C3H)F1 and  (A X bml2)F1,  respectively, as positive controls, to demonstrate 
that these cells were capable of suppressing F] mice in which an entire H-2 haplotype 
could be recognized. Thus, the B6 cells suppressed (B6 ×  C3H)F]  (Fig. 3A), and the 
bml2 suppressed (A ×  bm 12)F] (Fig. 3 B) CTL allogeneic responses. Most interesting 
was  the  observation  that  B6  and  bml2  spleen  cells  completely  abrogated  CTL 
potential  of (B6  X  bml2)F]  spleen  cells  to  B10.D2  (H-2 a)  alloantigens  (Fig.  3C). 
These results  indicate  that  I-A antigens  are  all  that  need  to  be recognized  by the 
inoculated  lymphocytes in order to induce profound CTL suppression. 
Discussion 
The findings of the present study indicate that parental lymphocytes injected into 
F1  mice need  to  recognize only I-A determinants  as  allogeneic to  induce  profound 
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FIG.  2.  In vitro CTL  potential to TNP-self of spleen cells from  F~  mice.  (A)  (AKM  X  MBR)F1 
mice were untreated  (C)) or injected with 6  ×  10  7 AKM  (&) or MBR  (V) spleen cells and tested  13 
d  later.  (B)  (2R  X  A)Fa  mice were untreated  (O)  or injected with 6  X  10  7 A  (A) or 2R  (V)  spleen 
cells and tested 7 d  later.  (C)  (A.TH  ×  A.TL)F1  mice were untreated  (C)) or injected with 5  X  10  7 
A.TL (A) spleen cells and tested 8  d  later. 940  GRAFT-VS.-ItOST-ASSOCIATED  IMMUNE  SUPPRESSION 
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FIo.  3.  In  vitro CTL  potential  to  BI0.D2  alloantigens of spleen  cells from  k'i mice.  (A)  (B6  X 
C3|t)FI  mice were untreated  (O) or it)iected with 5  x  I0  ~ B6 (A) spleen celts and tested  14 d  later. 
(B)  (A  x  bml2)F1  mice were  untreated  (O)  or  ir'tiected with  5  X  I0  v bml2  (V)  spleen cells and 
tested  14 d  later.  (C)  (B6  X  bml2)Fl  mice were untreated  (C)) or  injected with 5  x  10 7 B6  (A)  or 
bml2  (V)  spleen cells and tested  14 d  later. 
suppression of CTL responses to hapten-self (Figs.  1 and 2)  and to alloantigens  (Fig. 
3).  The results obtained  using a  series of B10  congenic and  recombinant  strains  as 
well as B6 and the bml2 mutant are summarized in Table I. The data indicate that 
in  any  combination  of parental  spleen  cells  into  F1  hosts  in  which  the  parental 
lymphocytes have the potential to recognize I-A determinants of the Fa as allogeneic, 
severe suppression  of CTL potential  was observed.  Furthermore,  the  data  indicate 
that  potential  recognition  of a  number of different  region  and  subregion  products 
that  do  not  include  I-A did  not  lead  to  suppression  by this  protocol.  It  should  be 
noted that we have limited this study to the suppressive effects of a single injection of 
parental  spleen  cells  and  have  not  yet  addressed  the  issue  of whether  multiple 
injections of parental cells into F1 mice involving recognition of determinants encoded 
by genes mapping to the right of I-A would be suppressive [e.g.,  4R into (4R X A)F1; 
Fig.  1 F].  Nevertheless,  our  results  demonstrate  a  striking  difference  in  suppressive 
potential initiated by I-A recognition vs. I-B-D recognition. 
The GVH reaction has been divided into two broad phases. The proliferative phase 
is considered (a) to be reflected in vivo by the splenomegaly or popliteal lymph node 
assay; (b)  to have an in vitro counterpart  in the mixed lymphocyte reaction; and  (c) 
to be stimulated mainly by I region (class [I) antigens, particularly those mapping to 
I-A (12-15). The effector phase is considered (a) to be reflected in vivo by the wasting 
syndrome and mortality;  (b)  to have an in  vitro counterpart  in the CTL assay; and 
(c) to involve the recognition of K  and D  region antigens  (class I), as well as I region 
antigens  (13,  15). In the effector phase, K, D, and I region-encoded products all can 
contribute  to  mortality  (14).  GVH-associated  acquisition  of host  H-2  antigens  by 
donor-derived T  cells also has been mapped to K, D, and I-A (16).  The results of the 
present study of GVH-associated immune suppression indicate a role for I-A, but not 
for K,  D, or any other  I  subregion  (Table I). The recognition  of I-C determinants 
resulting in GVH mortality was reported only after multiple injections of cells  (15). 
Studies  are  in  progress  to  determine  whether  GVH-associated  suppression  can  be 
induced  via I-E/C recognition  by multiple  injection  of F]  mice with  parental  cells 
that can recognize I-B-D-encoded determinants expressed by the F]. h  should also be 
noted that the recognition of I-E determinants in GVH results in the production  of 
autoantibodies  with  lupus-like  properties  (17).  This observation,  together  with  our 
demonstration  that  recognition of I-A antigens results in  immunosuppression, raises 
the possibility that the complex nature of GVH disease can be further resolved into 
distinct  entities by such genetic mapping studies. SHEARER  AND  LEVY 
TABLE  I 
Summary of Mapping of H-2 Recognition Required for Suppression 
941 
F~ recipient and H-2 alleles  Parental spleen  FI subregions  Suppression  Data shown in 
cell donor  allogeneic to  detected 
donor 
(C57BL/10 X BI0.A)F~ 
bbbbbbbb  B I  O.A 
kkkkkddd  kkkkkddd  K-D  Yes  Fig.  1 A 
[BI0.A(2R)  X C57BL/10]F~ 
kkkkkddb  B IO.A(2R) 
bbbbbbbb  kkkkkddb  K-S  Yes  Fig.  1 B 
kkkkkda"o  C57B L/10 
bbbbbbbb  bbbbbbbb  K-S  Yes  Fig.  1 B 
[B10.A(5R)  ×  BI0.AIF1 
bbbkkddd  B 10.A(5R) 
kkkkkddd  bbbkkddd  K-IB  Yes  Fig.  1 C 
[B 10.A(4R)  ×  C57BL/IO]F, 
kkbbbbbb  B 10.A(4R) 
bbbbbbbb  kkbbbbbbb  K, 1A  Yes  Fig.  1 D 
kkbbbbbb  C57BL/10 
bbbbbbbb  bbbbbbbb  K, 1A  Yes  Fig.  1 D 
(C57BL/10 X B 10.MBR)F1 
bbbbbbbb  C57BL/10 
bkkkkkkq  bbbbbbbb  IA-D  Yes  Fig.  1 E 
bbbbbbbb  B IO.MBR 
bkkkkkkq  bkkkkkkq  IA-D  Yes  Fig.  1E 
[BI0.A(4R)  ×  BI0.A]F1 
kkbbbbbb  BI0.A(4R) 
kkkkkddd  kkbbbbbb  IB-D  No  Fig.  1 F 
kkbbbbbb  B10.A  No  Fig.  1 F 
kkkkkddd  kkkkkddd  I B- D 
(B10.AKM x  B10. MBR)Fa 
kkkkkkkq  B 10.AKM 
bkkkkkkq  kkkkkkkq  K  No  Fig. 2 A 
kkkkkkkq  B 10. MRB  Fig. 2 A 
bkkkkkkq  bkkkkkkq  K  No 
(B10.A(2R)  X B10.A)F~ 
kkkkkddb  B 10.A(2R) 
kkkkkddd  kkkkkddb  D  No  Fig. 2 B 
kkkkkddb  B 10.A 
kkkkkddd  kkkkkddd  D  No  Fig. 2 B 
(A.TH x  A.TL)F~ 
sssssssd  A.TL 
skkkkkkd  skkkkkkd  IA-S  Yes  Fig. 2 C 
(C57BL/6 x  B6.cb~12)Fj 
bbbbbbbb  C57BL/6 
bb*bbbbbb  bbbbbbbb  IA  Yes  Fig. 3 C 
bbbbbbbb  B6.C  bm~2 
bb*bbbbbb  bb*bbbbbb  IA  Yes  Fig. 3 C 
halics indicate H-2, K, IA, IB, I  j, IE, IC, S, D, F1 alleles that are allogeneic to the parental donor. 
* Indicates gain-loss IA mutation of B6.C-H-2  b'12 strain. 942  GRAFT-VS.-HOST-ASSOCIATED IMMUNE SUPPRESSION 
The use of the B6 and  bml2  differences in the  parent  into  Fl-induced  immuno- 
suppression  has  permitted  the  mapping of this  phenomenon  to  the  I-A subregion, 
which indicates that recognition of other regions and subregions are not required.  In 
fact, no  differences were detected  in  the  severity of CTL suppression  in  this  study 
when combinations in which the entire H-2 could be recognized as allogeneic (Figs. 
1 A and 3 A and B) compared with combinations in which only I-A was recognized as 
allogeneic (Fig. 3 C). However, it is possible that the recognition of products of other 
H-2  regions  may contribute  to  some aspect  of suppression  such  as  the  number of 
parental cells required  to induce suppression or the time required  for recovery from 
suppression.  Furthermore,  this  study  has  not  addressed  the  issue  of whether  I-A 
recognition is all that is required for the induction of other GVH parameters such as 
splenomegaly, mortality, wasting syndrome, and the production of autoantibodies. 
This study also provides new information concerning the mutual recognition of the 
I-A differences between  the  C57BL/6  wild  type and  B6-C-H-2  bin12 mutant  strains. 
Thus, B6 and bml2 can be distinguished  from each other not only by graft rejection 
(9),  mixed  lymphocyte  reactivity  (9),  and  generation  of  CTL  (18),  but  also  by 
allogeneic I-A recognition leading to severe immunosuppression (Fig. 3 C). Thus, these 
findings  indicate  that  the  I-A  of  the  B6  and  bml2  differ  from  each  other  at 
determinants responsible for inducing immune suppression. 
The question can be raised whether the parental lymphocytes recognize only I-A of 
the other parental haplotype (B6 ×  bm 12)F1 expressed by the F1, or whether a unique 
I-A determinant  could possibly be recognized similar to that reported  for combina- 
tional I-A molecules of (C57BL/6  X  B10.A)F1  origin  (19).  It is unlikely that such a 
combinational I-A molecule can exist in the (B6 ×bm 12)F1 since the bm 12 mutation 
is limited to the Ab chain  (20).  This does not necessarily exclude the possibility that 
recognition  of an  F1  combinational  I-A molecule  in  the  appropriate  strains  would 
initiate suppression. 
The mechanism of immune suppression associated with GVH has been extensively 
investigated.  Arguments  that  suppression  is effected both by parental  anti-F1  CTL 
(21)  and  by  other  types  of  noncytotoxic  suppressor  cells  (22)  have  been  made. 
Although  the  present  study was not  designed  to  address  this  issue,  it  does provide 
some  insight  concerning  this  question.  The  fact  that  recognition  of allogeneic  I-A 
determinants is required  for induction  of expression does not exclude the possibility 
that suppression is due to CTL, since the antigeneic differences between B6 and bm 12 
are capable of eliciting CTL responses (18).  However, the fact that recognition of K 
or  D  differences  only  does  not  induce  suppression,  whereas  such  differences  are 
capable of eliciting  potent  CTL responses,  indicates  that  there  is  not  necessarily a 
direct correlation between those loci that elicit CTL responses and those that induce 
GVH-associated  suppression.  It  is  possible,  however,  that  CTL  generated  by  I-A 
differences uniquely function as suppressor cells in this system. 
It is not yet clear what the potential significance might be of immune suppression 
resulting  from  in  vivo  recognition  of  allogeneic  I-A  determinants.  In  allogeneic 
combinations involving immunocompetent recipients, the immune system of the host 
can  reject  the  donor's lymphocytes, and  the  immunosuppression seen  in  the GVH 
model would not be observed. However, in hosts that are incapable of rejecting donor 
lymphocytes such as parent into F1, or allogeneic combinations in which the immune 
system of the host  is impaired  (e.g., transplant  patients)  or not  yet developed  (e.g., SHEARER AND LEVY  943 
neonates), donor-induced activation of the type of suppression described in this study 
could  be critical.  In  this  context  it  should  be noted  that  Pollack  et  al.  (23)  have 
recently reported that some infants suffering from severe combined immunodeficiency 
disorders  (SCID)  are  chimeras  in  that  they possess maternal  T  lymphocytes. This 
observation raises the possibility that the immune deficiencies of these chimeric SCID 
are the result of an immune suppression mechanism similar to the GVH-associated 
immune suppression described here. If true, one might expect that all chimeric SCID 
patients  would  be  recognized  as  allogeneic  at  the  human  equivalent  of  I-A  by 
maternal T  lymphocytes for activation of this suppression. 
A second clinical situation in which "I-A-activated" immune suppression could be 
relevant  is in  hemopoietic transplantation.  Because GVH reactions are observed in 
transplant patients, many of whom are already immune suppressed, there may not be 
a general awareness of the profound suppressive potential that can accompany GVH. 
It should  be noted  that  patients  undergoing  chronic  GVH reactions  are unable  to 
cope  with  infections  and  appear  to  be  immune  suppressed  (24,  25).  Because  the 
routine  model  of GVH-associated  suppression  is  nonspecific  in  that  it  suppresses 
responses to all antigens except those to which the host had been primed (L. Joseph 
and G. M. Shearer, unpublished observations), this type of suppression should render 
the host very susceptible to infections. If the donor bone marrow inoculum contains 
T  lymphocytes  and  if  the  recipient  and  donor  are  mismatched  at  the  human 
equivalent  of I-A, e.g., DS  (26), even though HLA matched at other loci, including 
possibly DR and SB  (27), it is possible that an immunosuppressive signal similar to 
the one demonstrated  in  this report  could  impair the development of the  immune 
system of the reconstituted recipient without there necessarily being other symptoms 
of GVH disease. 
Finally,  a  third  clinical  situation  in  which  GVH-associated immune suppression 
may  be relevant  is  in  the  acquired  immune  deficiency syndrome  (AIDS)  recently 
reported mainly in male homosexuals (75%), but also detected  in other groups such 
as intravenous drug users and Haitians (28-31). GHV-associated suppression is similar 
to AIDS, both in  its lack of antigen  specificity and in  its severe and lasting effects. 
Thus, among the homosexuals affected, an etiology involving GVH-associated sup- 
pression  could  be  a  factor.  For example,  it  has  been  recently  observed  that  some 
homosexuals affected with AIDS have high antibody titers to sperm and appear to be 
undergoing anti-sperm autoimmune reactions (Rubenstein, personal communication). 
Such  autoimmunity  could  affect  the  blood-testes barrier and  result  in  abnormally 
high numbers of leukocytes in semen. These leukocytes could be transferred via semen 
to homosexual partners and  induce  GVH-associated immune suppression.  In order 
that the allogeneic leukocytes not be rejected, it would be necessary for the recipient 
of the leukocytes to be at  least transitionally  immune suppressed,  possibly by virus 
(32)  or sperm  (33).  Alternatively,  it would  not  be necessary for the recipient  to be 
immune suppressed to accept the leukocytes if the recipient were HLA heterozygous 
and  the  leukocyte  donors  were  HLA  homozygous  and  matched  with  one  of the 
recipient's haplotypes. Because the results of the present study demonstrate that I-A 
recognition is all that is required to initiate suppression, DS (26) recognition might be 
all that would be required to initiate AIDS. 
The present study has demonstrated a  new function for antigenic determinants of 
the  murine  I-A subregion,  i.e.,  the  activation  of a  potent  suppressive  signal  that 944  GRAFT-VS.-tlOST-ASSOCIATED IMMUNE  SUPPRESSION 
rapidly abrogates immunity.  Possible parallels between  this phenomenon  and  three 
examples of clinical immune deficiency have been considered. 
Summary 
Several combinations of F1 hybrid mice were injected intravenously with parental 
spleen cells to determine the minimal H-2 differences between F1 and parent that are 
necessary  to  induce  graft-vs.-host-associated immune  suppression  (GVH-associated 
suppression). 7-14 d after injection, the spleens of the F1 mice were tested for cytotoxic 
T  lymphocyte potential by in  vitro sensitization against trinitrophenyl-self and  H-2 
alloantigens.  The  results  indicate that  parental  T  lymphocytes must  recognize  I-A 
allogeneic determinants of the F1 recipient in order to induce suppression. Recognition 
of K  or D  alone or D with I region products other than I-A did not induce suppression. 
The recognition of I region without K  and/or D  and even the I-A difference between 
C57BL/6  and  the  B6.C bin12 mutation  resulted  in  immune  suppression  that  was  as 
potent  as that  resulting  from  the recognition of K,  D,  and  I  together.  The  possible 
significance of this function for I-A antigens is discussed with respect to three clinical 
examples of immune suppression for which this phenomenon  may be relevant. 
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